GNI is solving the critical industry problem of declining drug revenues and increased R&D costs in the post-genomic era. | ||
GNI's founders and scientists are some of the world's leading experts in laboratory and computational techniques designed to understand the hierarchical network control relationships among genes. In addition, GNI applies the same efficient and high quality design and manufacturing processes to the post-genome drug design process as Japanese companies have made legendary in other industries such as automobiles and electronic devices. We have leveraged these scientific and industrial technologies to create a platform that transforms molecular target selection into a rational, iterative design and manufacturing process. | ||
Our Mission... Our Focus... |